Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Insider transactions

Published ▼ Stock Transactionratings Value Name Relevance
2024-03-12 Deutsche Pfandbriefbank AG buy €20,552 Hagen, Dr. Louis
Aufsichtsrat
2024-03-08 Grenke AG buy €49,415 Rösler, Isabel
Vorstand
2024-03-01 Hamborner REIT AG buy €12,600 Karoff, Niclas
Vorstand
2024-03-01 Hamborner REIT AG buy €18,930 Karoff, Niclas
Vorstand
2024-02-20 Hamborner REIT AG buy €25,560 Verheyen, Sarah
Vorstand
2024-01-08 Grenke AG buy €49,000 Hirsch, Dr. Sebastian
Vorstand
2023-12-01 DIC Asset AG buy €36,049 Fritzsche, Christian
Vorstand
2023-11-23 Dermapharm Holding SE buy €15,216,000 Themis Beteiligungs-Aktiengesellschaft
in enger Beziehung
2023-10-25 Hamborner REIT AG buy €12,293 Böge, Claus-Matthias
Aufsichtsrat
2023-10-19 Grenke AG buy €10,841 Hirsch, Dr. Sebastian
Vorstand
2023-10-09 Hamborner REIT AG buy €24,840 Verheyen, Sarah
Vorstand
2023-10-09 Grenke AG buy €18,745 Hirsch, Dr. Sebastian
Vorstand
2023-08-24 Hamborner REIT AG buy €44,825 Karoff, Niclas
Vorstand
2023-08-22 Grenke AG buy €23,250 Hirsch, Dr. Sebastian
Vorstand
2023-08-16 Hamborner REIT AG buy €5,280.0 Mattner, Dr. Andreas
Aufsichtsrat
2023-06-30 Hamborner REIT AG buy €12,760 Verheyen, Sarah
Vorstand
2023-06-29 Hamborner REIT AG buy €24,469 Verheyen, Sarah
Vorstand
2023-06-28 Hamborner REIT AG buy €32,306 Karoff, Niclas
Vorstand
2023-06-28 Medios AG buy €39,100 Prußeit, Christoph
Vorstand
2023-06-28 Hamborner REIT AG buy €19,410 Karoff, Niclas
Vorstand
2023-06-27 Dermapharm Holding SE buy €99,901 Feldmeier, Dr. Hans-Georg
Vorstand
2023-06-20 Hamborner REIT AG buy €13,700 Verheyen, Sarah
Vorstand
2023-05-24 Hamborner REIT AG buy €19,980 Verheyen, Sarah
Vorstand
2023-05-24 Hamborner REIT AG buy €8,149.0 Verheyen, Sarah
Vorstand
2023-05-22 Hamborner REIT AG buy €5,023.0 Mattner, Dr. Andreas
Aufsichtsrat